Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.3404
-0.0126 (-3.57%)
At close: Jul 2, 2026, 4:00 PM EDT
0.3300
-0.0104 (-3.06%)
After-hours: Jul 2, 2026, 5:31 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $16.54 million as of July 2, 2026. Its market cap has decreased by -69.53% in one year.
Market Cap
16.54M
Enterprise Value
7.74M
1-Year Change
-69.53%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $16.54M, a decrease of -96.24%. That is a compound annual growth rate of -46.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 16.54M | -46.20% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 18.13M |
| GT Biopharma | 17.01M |
| Quince Therapeutics | 16.85M |
| Moolec Science | 16.57M |
| Chemomab Therapeutics | 16.34M |
| Vyome Holdings | 16.14M |
| Tempest Therapeutics | 16.14M |
| Citius Pharmaceuticals | 15.77M |